The nuclear translocation of ERK1/2 as an anticancer target. [electronic resource]
Producer: 20160325Description: 6685 p. digitalISSN:- 2041-1723
- Active Transport, Cell Nucleus -- drug effects
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Blotting, Western
- CHO Cells
- Cell Line, Tumor
- Cell Nucleus -- drug effects
- Cell Survival -- drug effects
- Cricetulus
- HCT116 Cells
- HeLa Cells
- Humans
- Immunohistochemistry
- Immunoprecipitation
- In Situ Nick-End Labeling
- Mice, Nude
- Mice, SCID
- Microscopy, Fluorescence
- Mitogen-Activated Protein Kinase 1 -- metabolism
- Mitogen-Activated Protein Kinase 3 -- metabolism
- Molecular Targeted Therapy
- Neoplasm Transplantation
- Peptides -- pharmacology
- Protein Transport -- drug effects
- Xenograft Model Antitumor Assays
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.